Astena Holdings Co., Ltd.

8095

JP3150000002

Pharmaceuticals

Delayed Japan Exchange Other stock markets 03:30:00 27/06/2024 BST			5-day change	1st Jan Change
551 ^JPY	+3.57%		+8.46%	+15.76%

2022	Tranche Update on Astena Holdings Co., Ltd.'s Equity Buyback Plan announced on July 13, 2022.	CI
2022	Astena Holdings Co., Ltd.'s Equity Buyback announced on July 13, 2022 has closed with 676,400 shares, representing 1.69% for ¥299.97 million.	CI

Iwaki & Co., Ltd. announced that it has received ¥9.6096 million in funding from SMBC Nikko Securities Inc., Investment Arm

December 15, 2020

On December 16, 2020, Iwaki & Co., Ltd. (TSE:8095) closed the transaction.

Latest news about Astena Holdings Co., Ltd.

Tranche Update on Astena Holdings Co., Ltd.'s Equity Buyback Plan announced on July 13, 2022.	21/09/22	CI
Astena Holdings Co., Ltd.'s Equity Buyback announced on July 13, 2022 has closed with 676,400 shares, representing 1.69% for ¥299.97 million.	15/09/22	CI
Tranche Update on Astena Holdings Co., Ltd.'s Equity Buyback Plan announced on July 13, 2022.	01/09/22	CI
Astena Holdings Co., Ltd. announces an Equity Buyback for 900,000 shares, representing 2.25% for ¥300 million.	13/07/22	CI
Astena Holdings Co., Ltd. authorizes a Buyback Plan.	12/07/22	CI
Insider Trends: MediciNova Insider Reports Option Conversion Extending 90-Day Buying Trend	23/07/21	MT
Tokyo Electric Power Incorporated : Olympic torch relay stirs mixed emotions ahead of its Fukushima start	24/03/21	RE
Tokyo Electric Power Incorporated : Olympic torch relay stirs mixed emotions ahead of its Fukushima start	24/03/21	RE
Daio Paper : Subsidiaries to Sell Shares in Parent Company	12/03/21	MT
Iwaki : Attributable Profit Drops Over 8% in Fiscal Nine Months 2020	08/03/21	MT
Insider Trends: Insider at MediciNova Converts Options Amid 90-Day Selling Trend	03/03/21	MT
Iwaki & Co., Ltd. cancelled the acquisition of Spera Pharma, Inc. from Bushu Pharmaceuticals Ltd.	23/01/21	CI
Iwaki & Co., Ltd. announced that it has received ¥9.6096 million in funding from SMBC Nikko Securities Inc., Investment Arm	15/12/20	CI
Iwaki & Co., Ltd. announced that it expects to receive ¥9.6096 million in funding from SMBC Nikko Securities Inc., Investment Arm	29/11/20	CI
Iwaki & Co., Ltd. agreed to acquire Maruman H&B Co.,Ltd. from MAJESTY GOLF Co., Ltd for ¥1 billion.	18/11/20	CI
Iwaki & Co., Ltd. signed a share transfer agreement to acquire Spera Pharma, Inc. from Bushu Pharmaceuticals Ltd. for ¥6 billion.	26/01/20	CI
Maeda Pharmaceutical Industry Co., Ltd. announced that it expects to receive funding from Iwaki & Co., Ltd.	26/01/20	CI
TechnoEcho Co., Ltd. acquired a 30% stake in Astena Holdings Co., Ltd..	25/12/19	CI
Iwaki Co., Ltd. agreed to acquire remaining 30% stake in TechnoEcho Co., Ltd. from Noriyuki Yamanaka and Makoto Nagase, Directors of Iwaki for approximately ¥160 million.	12/12/19	CI
Asco Co., Ltd. agreed to acquire Hokuyaku Co., Ltd. and A?M?I Co., Ltd. from Iwaki & Co., Ltd..	30/07/19	CI
Dalton Investments Submits Shareholder Proposal to Iwaki	20/11/18	CI
Iwaki & Co., Ltd.(TSE:8095) added to S&P Global BMI Index	18/09/17	CI
Iwaki Co., Ltd. completed the acquisition of 70% stake in TechnoEcho Co., Ltd.	25/12/16	CI
Iwaki Co., Ltd. agreed to acquire 70% stake in TechnoEcho Co., Ltd..	14/12/16	CI
Tranche Update on Iwaki & Co., Ltd.'s Equity Buyback Plan announced on April 12, 2016.	26/04/16	CI

Chart Astena Holdings Co., Ltd.

Duration

Period

More charts

Astena Holdings Co Ltd, formerly Iwaki & Co Ltd is a Japan-based company primarily engaged in the fine chemicals business, medical business, health & beauty care (HBC) and food business, and industrial chemicals business. The Company operates through four business segments. The Fine Chemicals segment is engaged in manufacture and sale of pharmaceutical raw materials and pharmaceuticals. The Medical segment is engaged in the manufacturing and sales of pharmaceutical products. The HBC and Food segment is engaged in the manufacture and sale of cosmetic raw materials, functional food raw materials, general use medicines and related products, as well as cosmetics. The Industrial Chemicals segment manufactures and sells chemicals for electronic industries, surface treatment chemicals, chemical products, surface treatment chemical raw materials, as well as to printed circuit board and other manufacturing plants. The other businesses include consulting services and others.

Sector

Pharmaceuticals

Calendar

11/07/2024 - Q2 2024 Earnings Release

More about the company

	1st Jan change	Capi.
ASTENA HOLDINGS CO., LTD.	+15.76%	128M
ELI LILLY AND COMPANY	+54.61%	815B
NOVO NORDISK A/S	+44.25%	654B
JOHNSON & JOHNSON	-6.33%	354B
MERCK & CO., INC.	+20.62%	337B
ABBVIE INC.	+10.44%	302B
ASTRAZENECA PLC	+18.45%	247B
ROCHE HOLDING AG	+2.09%	229B
NOVARTIS AG	+13.03%	219B
AMGEN INC.	+8.61%	171B

Other Pharmaceuticals

Astena Holdings Co., Ltd.

Equities

8095

JP3150000002

Pharmaceuticals

Iwaki & Co., Ltd. announced that it has received ¥9.6096 million in funding from SMBC Nikko Securities Inc., Investment Arm

Latest news about Astena Holdings Co., Ltd.

Chart Astena Holdings Co., Ltd.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals